Rabies is a deadly disease and endemic in over 100 countries. It causes around 59,000 human deaths annually, the vast majority in Asia and Africa. There are safe and effective human vaccines for pre- and post-exposure prophylaxis. With a prompt and proper post-exposure prophylaxis (PEP), exposed people have a survival rate close to 100%.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 August - 5 Sep 2020 and includes updates on COVID-19, Ebola virus disease, MERS, Dengue, CCHF, West Nile Virus.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 September-5 October 2019 and includes updates on COVID-19 associated with SARS-CoV-2, Crimean-Congo Haemorrhagic fever – Europe – 2020, West Nile virus - Monitoring season 2020, Monitoring of the environmental suitability of Vibrio growth in the Baltic Sea - Summer 2020, Ebola virus disease - eleventh outbreak - Democratic Republic of the Congo - 2020 and dengue in the French Antilles - 2020.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 July 2020 and includes updates on COVID-19, Ebola virus disease, vibrio, West Nile Virus and measles.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 June - 4 July 2020 and includes updates on COVID-19, Ebola virus disease, polio, vibrio, West Nile Virus and lyssavirus.
This issue of the CDTR (Communicable Disease Threats Report) covers the period from 7-13 June 2020 and includes updates on COVID-19, Crimean-Congo haemorrhagic fever, Ebola and West Nile fever.
Depending on the level of evidence provided and the methodology used, this advice is typically conveyed through a Guidance, a Systematic review or an Expert opinion.
HIV combination prevention is an approach that brings together single prevention initiatives into a comprehensive programme. This approach considers that the offer of multiple evidence-based interventions in a comprehensive programme will have a greater impact on HIV transmission than investing in a single strategy. In this report we
present and test the feasibility of a novel approach to monitoring the implementation of combination HIV prevention at national level.
European Testing Week is a European campaign that encourages partner organisations, in community, health care and policy institutions, throughout Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing.